Announcements
- EQS-DD: BB BIOTECH AG: Dr. Thomas von Planta, buy
- EQS-News: Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share
- EQS-DD: BB BIOTECH AG: Prof. Dr. Mads Krogsgaard Thomsen, buy
- EQS-Adhoc: BB Biotech AG publishes its 2023 annual report
- EQS-News: Investor interest returns – dividend yield remains high for 2024
- EQS-Adhoc: BB Biotech AG publishes financial results for 2023 and changes to the Board of Directors
- EQS-News: BB Biotech AG: End of year biotech equity market rally – M&A and end of rate hike cycle
More ▼
Key statistics
As of last trade BB Biotech AG (BBZX.N:GER) traded at 46.80, -11.03% below its 52-week high of 52.60, set on Feb 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 46.30 |
---|---|
High | 46.90 |
Low | 46.20 |
Bid | 46.50 |
Offer | 46.80 |
Previous close | 45.90 |
Average volume | 32.36k |
---|---|
Shares outstanding | 55.40m |
Free float | 54.42m |
P/E (TTM) | -- |
Market cap | 2.50bn CHF |
EPS (TTM) | -3.76 CHF |
Annual div (ADY) | 2.05 EUR |
---|---|
Annual div yield (ADY) | 4.47% |
Div ex-date | Mar 25 2024 |
Div pay-date | Mar 27 2024 |
Data delayed at least 15 minutes, as of Mar 28 2024 15:15 BST.
More ▼